A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
3
PDA, HFD-602, Rockville
|
4
TSRL, Inc., Ann Arbor
|
Publication type: Journal Article
Publication date: 1995-01-01
scimago Q1
wos Q1
SJR: 0.871
CiteScore: 6.8
Impact factor: 4.3
ISSN: 07248741, 1573904X
PubMed ID:
7617530
Organic Chemistry
Pharmacology
Pharmaceutical Science
Molecular Medicine
Pharmacology (medical)
Biotechnology
Abstract
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating invivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which noin vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes. This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estimating the absorption of drugs based on the fundamental dissolution and permeability properties of physiologic importance.
Found
Nothing found, try to update filter.
Top-30
Journals
|
50
100
150
200
250
300
|
|
|
International Journal of Pharmaceutics
281 publications, 6.8%
|
|
|
Journal of Pharmaceutical Sciences
268 publications, 6.48%
|
|
|
European Journal of Pharmaceutical Sciences
205 publications, 4.96%
|
|
|
Molecular Pharmaceutics
184 publications, 4.45%
|
|
|
European Journal of Pharmaceutics and Biopharmaceutics
141 publications, 3.41%
|
|
|
Drug Development and Industrial Pharmacy
118 publications, 2.85%
|
|
|
Pharmaceutics
114 publications, 2.76%
|
|
|
Pharmaceutical Research
105 publications, 2.54%
|
|
|
AAPS PharmSciTech
100 publications, 2.42%
|
|
|
AAPS Journal
80 publications, 1.94%
|
|
|
Journal of Drug Delivery Science and Technology
79 publications, 1.91%
|
|
|
Crystal Growth and Design
78 publications, 1.89%
|
|
|
Journal of Pharmacy and Pharmacology
58 publications, 1.4%
|
|
|
Advanced Drug Delivery Reviews
45 publications, 1.09%
|
|
|
Journal of Controlled Release
44 publications, 1.06%
|
|
|
Pharmaceutical Development and Technology
43 publications, 1.04%
|
|
|
Journal of Pharmaceutical and Biomedical Analysis
30 publications, 0.73%
|
|
|
Molecules
29 publications, 0.7%
|
|
|
AAPS Advances in the Pharmaceutical Sciences Series
29 publications, 0.7%
|
|
|
Biopharmaceutics and Drug Disposition
28 publications, 0.68%
|
|
|
Brazilian Journal of Pharmaceutical Sciences
26 publications, 0.63%
|
|
|
Expert Opinion on Drug Metabolism and Toxicology
24 publications, 0.58%
|
|
|
Therapeutic Delivery
23 publications, 0.56%
|
|
|
Journal of Medicinal Chemistry
23 publications, 0.56%
|
|
|
Expert Opinion on Drug Delivery
23 publications, 0.56%
|
|
|
Journal of Pharmaceutical Investigation
21 publications, 0.51%
|
|
|
Drug Discovery Today
20 publications, 0.48%
|
|
|
Clinical Pharmacokinetics
20 publications, 0.48%
|
|
|
Lipophilicity in Drug Action and Toxicology
20 publications, 0.48%
|
|
|
50
100
150
200
250
300
|
Publishers
|
200
400
600
800
1000
1200
1400
1600
|
|
|
Elsevier
1594 publications, 38.56%
|
|
|
Springer Nature
597 publications, 14.44%
|
|
|
Wiley
389 publications, 9.41%
|
|
|
American Chemical Society (ACS)
355 publications, 8.59%
|
|
|
Taylor & Francis
352 publications, 8.51%
|
|
|
MDPI
214 publications, 5.18%
|
|
|
Royal Society of Chemistry (RSC)
66 publications, 1.6%
|
|
|
Bentham Science Publishers Ltd.
34 publications, 0.82%
|
|
|
Hindawi Limited
31 publications, 0.75%
|
|
|
Pharmaceutical Society of Japan
26 publications, 0.63%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
22 publications, 0.53%
|
|
|
19 publications, 0.46%
|
|
|
Frontiers Media S.A.
18 publications, 0.44%
|
|
|
Georg Thieme Verlag KG
18 publications, 0.44%
|
|
|
Pharmaceutical Society of Korea
15 publications, 0.36%
|
|
|
Oxford University Press
13 publications, 0.31%
|
|
|
Pleiades Publishing
11 publications, 0.27%
|
|
|
King Saud University
11 publications, 0.27%
|
|
|
SciELO
10 publications, 0.24%
|
|
|
International Union of Crystallography (IUCr)
9 publications, 0.22%
|
|
|
Mary Ann Liebert
9 publications, 0.22%
|
|
|
AIP Publishing
7 publications, 0.17%
|
|
|
SAGE
7 publications, 0.17%
|
|
|
Shenyang Pharmaceutical University
7 publications, 0.17%
|
|
|
Public Library of Science (PLoS)
6 publications, 0.15%
|
|
|
IntechOpen
6 publications, 0.15%
|
|
|
IOP Publishing
5 publications, 0.12%
|
|
|
Cold Spring Harbor Laboratory
5 publications, 0.12%
|
|
|
Beilstein-Institut
4 publications, 0.1%
|
|
|
200
400
600
800
1000
1200
1400
1600
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4.1k
Total citations:
4135
Citations from 2024:
341
(8.25%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Amidon G. L. et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability // Pharmaceutical Research. 1995. Vol. 12. No. 3. pp. 413-420.
GOST all authors (up to 50)
Copy
Amidon G. L., Lennernäs H., Shah V. P., Crison J. R. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability // Pharmaceutical Research. 1995. Vol. 12. No. 3. pp. 413-420.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1023/A:1016212804288
UR - https://doi.org/10.1023/A:1016212804288
TI - A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
T2 - Pharmaceutical Research
AU - Amidon, Gordon L.
AU - Lennernäs, Hans
AU - Shah, Vinod P
AU - Crison, John R
PY - 1995
DA - 1995/01/01
PB - Springer Nature
SP - 413-420
IS - 3
VL - 12
PMID - 7617530
SN - 0724-8741
SN - 1573-904X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{1995_Amidon,
author = {Gordon L. Amidon and Hans Lennernäs and Vinod P Shah and John R Crison},
title = {A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability},
journal = {Pharmaceutical Research},
year = {1995},
volume = {12},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1023/A:1016212804288},
number = {3},
pages = {413--420},
doi = {10.1023/A:1016212804288}
}
Cite this
MLA
Copy
Amidon, Gordon L., et al. “A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability.” Pharmaceutical Research, vol. 12, no. 3, Jan. 1995, pp. 413-420. https://doi.org/10.1023/A:1016212804288.